IGF-1 is also implicated in castration-resistant PCa and has been shown to activate androgen receptor (AR) signaling in prostate cancer cells via the IGF-1R-forkhead box protein O1 (FOXO1) signaling axis (Figure 1) (55–57). This evidence concerns the gene IGF1 and prostate carcinoma.